Sagent Busulfan Injection Recall: Failed Impurities Risk
Sagent Pharmaceuticals recalls Busulfan injection vials due to potential impurities. Affected lots expire 08/31/2026 and 03/31/2027. Contact for return instructions.
Recall notice
Failed Impurities/Degradation Specifications
Contact the company
What happened, in plain English
Sagent Pharmaceuticals is recalling Busulfan injection vials that may contain impurities. This could affect patients using the medication as part of their cancer treatment. The recall is for specific lots with expiration dates in 2026 and 2027. Read more at govinfonow.com/recall/31317-sagent-busulfan-injection-recall-failed-impurities-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/31317-sagent-busulfan-injection-recall-failed-impurities-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0539-2026
Cite this page
“Sagent Busulfan Injection Recall: Failed Impurities Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31317-sagent-busulfan-injection-recall-failed-impurities-risk. Based on FDA recall #D-0539-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0539-2026%22&limit=1).
Why it’s dangerous
The vials may contain impurities that could affect the medication's safety and effectiveness. This could lead to adverse reactions in patients receiving the drug for cancer treatment.
Who’s affected
Patients prescribed Busulfan injection for cancer treatment who own the recalled vials. Those using the medication as directed are most at risk.
How to tell if you have this one
Check for vials labeled 'Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only'. Look for lot numbers 656412 (expiring 08/31/2026) or 659646 (expiring 03/31/2027).
- Brand
Sagent Pharmaceuticals- Category
Drug
What to do — step by step
Check Vial Details
Identify the lot number and expiration date on the vial label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 23 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0539-2026 (May 4, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0539-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.